All eyes are on the Supreme Court this week, as the temporary stay in the Texas mifepristone case expires. Andy speaks with Fatima Goss Graves from the National Women’s Law Center about the confusing rulings and what she expects the justices to do. Former FDA Commissioner Josh Sharfstein also joins to explain the dangerous precedent this case could set for FDA-approved drugs and drug development.

Keep up with Andy on Post and Twitter @ASlavitt.

Follow Fatima Goss Graves and Joshua Sharfstein on Twitter ​​@FGossGraves and @drJoshS.

Joining Lemonada Premium is a great way to support our show and get bonus content. Subscribe today at bit.ly/lemonadapremium. 

Support the show by checking out our sponsors!

• Click this link for a list of current sponsors and discount codes for this show and all Lemonada shows: https://lemonadamedia.com/sponsors/ 

Check out these resources from today’s episode: 

• Read Josh’s opinion piece, “I Worked at the F.D.A. The Abortion Pill Decision Is Dangerous”: https://www.nytimes.com/2023/04/10/opinion/fda-mifepristone.html
• Check out In the Bubble’s new merch: https://lemonadamedia.com/shop/
• Find vaccines, masks, testing, treatments, and other resources in your community: https://www.covid.gov/
• Order Andy’s book, “Preventable: The Inside Story of How Leadership Failures, Politics, and Selfishness Doomed the U.S. Coronavirus Response”: https://us.macmillan.com/books/9781250770165 

Stay up to date with us on Twitter, Facebook, and Instagram at @LemonadaMedia. 

For additional resources, information, and a transcript of the episode, visit lemonadamedia.com/show/inthebubble.